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Abstract 
Introduction; Intrauterine infection/inflammation is associated with preterm delivery (PTD) and severe neonatal 
morbidity. Inflammation is also important in the secondary neurotoxic cascade leading to perinatal brain injury. 
The aims were to investigate (a) the novel inflammatory marker galectin-3 that affects accumulation, apoptosis 
and activation of inflammatory cells and (b) free radical formation in particular by the enzyme NADPH-oxidase 
responsible for free radical formation in inflammatory cells,  in threatening PTD (III) and in the development of 
experimental perinatal brain injury (I,II).  
Materials and methods; Amniotic fluid (AF) and placentas were obtained from 83 women with threatening PTD 
presenting with preterm labour (PTL) or premature prelabour rupture of membranes (pPROM) and from 15 term 
controls. AF was analysed for galectin-3, ascorbyl radicals and antioxidative capacity (AOC) and results were 
correlated to signs of intrauterine infection/inflammation, PTD and severe neonatal morbidity (III). In the 
experimental studies, models of term hypoxia-ischemia (HI) (I,II) and of excitotoxic white matter injury (I) were 
used in knock-out (KO) mice for galectin-3 (II) and gp91phox (a subunit in NADPH-oxidase) (I) and together with 
two inhibitors of NADPH oxidase (I). Lesion size, inflammation (microglia accumulation, inflammatory 
mediators), free radical formation, apoptosis and trophic factors were studied. In vitro studies were used to 
investigate free radical formation in microglial cells (I) and the effect of AF on pre-activated neutrophils (III).  
Results; Galectin-3, ascorbyl radicals and AOC were detected in all AF samples. Women with threatening PTD 
and infection/inflammation had higher levels of galectin-3 and slow AOC but lower levels of ascorbyl radicals 
than term controls but without correlation to PTD. Mothers of girls had higher levels galectin-3 than mothers of 
boys. AF also quenched free radical formation in primed neutrophils in vitro. Women with PTL did not differ 
from women with pPROM. Only AOC was increased in mothers to infants with severe morbidity (III). After 
experimental HI, mRNA expression of galectin-3 and NADPH-oxidase subunits (I,II) as well as galectin-3 protein 
expression were increased (II). Galectin-3 KO mice had reduced injury but increased microglial density and 
reduced expression of inflammatory factors (MMP-9) and markers for oxidative stress (nitrotyrosine). The 
protection was more pronounced in males. Apoptosis was altered in un-operated KO mice but not after HI. No 
difference was seen for trophic factors (II). Pharmacological inhibition of NADPH-oxidase reduced free radical 
formation in vitro and markers of oxidative stress in vivo, but resulted in an increase in apoptotic markers and 
lesion size after excitotoxic injury. Genetic inhibition did not reduce injury but resulted in an increase of the 
inflammatory markers galectin-3 and IL-1β (I). 
Conclusion; Galectin-3 is increased in women with threatening PTD and associated infection/inflammation,but 
our findings suggest a strong antioxidative capacity and not an increased oxidative stress as previously suggested 
(III). Galectin-3 contributes to neonatal brain injury by modulating the inflammatory response rather than affecting 
apoptosis or trophic factors and the mechanisms may be sex dependent (II). Contrary to findings in the adult brain, 
perinatal brain injury was unaltered or aggravated after genetic and pharmacological NADPH-oxidase inhibition 
(I). 
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injury, NADPH oxidase, galectin-3, MMP-9, ascorbyl radicals, antioxidative capacity.   
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